We dont currently handle insurance (including Medicare) or prior authorizations for GLP-1s, but please check back soon
Lancet 372(9645):12401250 Drucker DJ, Sherman SI, Gorelick FS, Bergenstal RM, Sherwin RS, Buse JB (2010) Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits
GLPs are redefining expectations by integrating weight, glycemic control, and cardiometabolic risk into one cohesive treatment approach
By introducing these beneficial bacteria, you may be able to reduce the severity of side effects while improving your overall digestive health
1 Like AlexKChen March 5, 2025, 1:20pm #70 I have chronic fatigue (too tired to do things half the time) and ADHD-PI, it makes consistent strength training extremely difficult but beyond those excuses
Drugs like Ozempic, Wegovy, and Mounjaro have taken America by storm